BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT

Earnings: Dentsply Sirona Q4 profit beats despite revenue drop; stock jumps

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday. At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above […]

March 1, 2019 2 min read
News

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday. At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above […]

Dentsply Sirona (XRAY), a provider of dental products and technology, reported a decline in earnings and revenues for the fourth quarter of 2018. However, the results exceeded the consensus analysts’ estimate, driving the stock higher on Friday.

An infographic on DENTSPLY SIRONA's fourth quarter 2018 earnings results
DENTSPLY SIRONA Q4 2018 Earnings Infographic

At $1.06 billion, net sales were down 2.9% from the prior-year quarter. The top-line came in slightly above the forecast. A 4.6% revenue growth in Europe and a 1.4% gain in rest of the world were eclipsed by a 14.7% contraction in the US amid hectic destocking by dealers.

Among the product categories, Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the company’s European distribution center. Meanwhile, Technology & Equipment revenue fell by 7.4%.

Consumable revenue rose 3.4% annually, helped by the recent recovery in shipments at the European distribution center

Adjusted earnings dropped to $0.58 per share during the three-month period from $0.82 per share in the fourth quarter of 2017. Reported profit was $1.8 million or $0.01 per share, compared to a loss of $650.4 million or $2.85 share in the year-ago quarter.

Related: Dentsply Q3 2018 Earnings Conference Call Transcript

“We have completed a top to bottom diagnostic of the Company and are executing a major restructuring plan to accelerate growth, improve margins and simplify our business,” said CEO Don Casey.

For fiscal 2019, the management expects adjusted earnings in the range of $2.25 per share to $2.40 per share, which represents a 12-19% annual growth. The forecast for full-year reported revenue is $3.95-$4.05 billion. The top line will be negatively impacted by the ongoing portfolio shaping initiatives and unfavorable exchange rates.

Also read: Johnson & Johnson buys Auris Health

Internal sales are estimated to grow between 4% and 5% this year, benefitting from new product launches and the absence of dealer destocking. Going forward, the efforts to simplify the organizational structure, such as consolidation of the dental product groups and regional commercial groups, are expected to strengthen performance.

Shares of Dentsply surged about 8% in the pre-market hours Friday following the earnings report, after closing the previous session higher. Since the beginning of 2019, the stock gained more than 10%.

Get access to timely and accurate verbatim transcripts that are published within hours of the event

ADVERTISEMENT